P51 Pneumonia and respiratory failure after chemotherapy: never overlook Pneumocystis jirovecii
P53 Sepsis after cardiac surgery: preliminary analysis of cytokines gene expression
P57 Traversing the Diagnostic Labyrinth: The Lethal Outcome of Chronic Granulomatous Meningitis
P58 Surveillance for C. auris and clinical impact in infectious therapy: is the monster still scary?
P59 Clinical-histopathological correlation of myocardial injury in severe COVID-19
P60 Biomarkers trajectories in critically ill patients with COVID-19: a latent class growth analysis
P14 Systemic and pulmonary embolization through patent foramen ovale
P16 Extracorporeal Cardio-Pulmonary Resuscitation program: a single centre retrospective experience.
P19 Left atrial pump mechanism during cardiopulmonary resuscitation
P20 Adrenergic drugs administration in cardiogenic shock: results from a perspective data collection
P22 Prognostic Role of Lung Ultrasound in Cardiogenic Shock Patients: A Prospective Registry Study
P23 Fatal cardiogenic shock in severe myocardial hypertrophy due to primary hyperparathyroidism
P24 A case of Takotsubo Syndrome in a smoker with rhinovirus pneumonia
P64 Antithrombin and D-Dimer levels according to Bleeding and Thrombosis Events at ECMO initiation
P65 Case report: malignant cerebral edema in VA ECMO
P67 Does Body Mass Index impact mortality in hospitalized critically ill patients in the ICU?
P70 Neurointensive Care in Lombardia: a step ahead in the definition of a regional network
P71 Revisiting Sorrentinos ICP threshold in a tertiary center twelve years later
P91 Evaluation of Venturi Devices for CPAP Application in Emergency Settings
P92 Is SpO2/FiO2 a surrogate of PaO2/FiO2 in ARDS assessment?
P93 Target of transpulmonary pressure to prevent expiratory lung collapse and cyclic opening-closing
P95 Lung superimposed pressure in pediatric acute respiratory distress syndrome